Phio Pharmaceuticals Announces Agreement with U.S. cGMP Manufacturing Source for Drug Product, PH-762

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/2/2026

1. SPY
2. TSLA
3. META
4. HOOD
5. STZ
6. INTC
7. SPCX
8. GOOGL
9. FDS
10. FUTU

Go back to Phio Pharmaceuticals Announces Agreement with U.S. cGMP Manufacturing Source for Drug Product, PH-762

Phio Pharmaceuticals signs manufacturing agreement for cancer drug

March 30, 2026 7:18 AM EDT

Phio Pharmaceuticals Corp. (NASDAQ: PHIO) announced it has entered into a manufacturing services agreement with a U.S. manufacturer for clinical supply of its lead compound PH-762. The agreement covers both clinical and commercial supply manufacturing for future clinical trials.

The clinical-stage biopharmaceutical... More